| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.103.2.231 |
| P698 | PubMed publication ID | 11208682 |
| P2093 | author name string | Reichart B | |
| Loebe M | |||
| Pavie A | |||
| Gronda E | |||
| Portner PM | |||
| Vigano M | |||
| El-Banayosy A | |||
| Loisance DY | |||
| Deng MC | |||
| Wheeldon DR | |||
| Mesana T | |||
| Vitali E | |||
| Jansen PG | |||
| Wieselthaler GM | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 231-237 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome | |
| P478 | volume | 103 |
| Q37653938 | Assessment of right ventricular function in left ventricular assist device candidates. |
| Q46129739 | Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support. |
| Q37247231 | Clinical manifestations and management of left ventricular assist device-associated infections. |
| Q35146905 | Devices as destination therapy |
| Q39416392 | Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy |
| Q34079591 | Early adverse events as predictors of 1-year mortality during mechanical circulatory support |
| Q35155663 | Early and late results of partial left ventriculectomy: single center experience and review of the literature |
| Q51174179 | Effect of age on outcomes after left ventricular assist device placement. |
| Q85237399 | Electrophysiological interactions between implantable cardioverter defibrillators and left ventricular assist device |
| Q35146897 | Extracorporeal mechanical circulatory assist. |
| Q36647792 | Heart failure and mechanical circulatory assist devices |
| Q51093682 | Importance of luxury flow for critically ill patients receiving a left ventricular assist system. |
| Q42246076 | Infectious Complications of Mechanical Circulatory Support (MCS) Devices |
| Q38429229 | Integrative model of leukocyte genomics and organ dysfunction in heart failure patients requiring mechanical circulatory support: a prospective observational study |
| Q28209612 | Late bleeding from right internal mammary artery after HeartMate left ventricular assist device implantation |
| Q30233364 | Left Ventricular Assist Devices as Destination Therapy |
| Q40557615 | Left ventricular assist devices as permanent heart failure therapy: the price of progress |
| Q36070735 | Left ventricular assist devices: an evidence-based analysis |
| Q51722021 | Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. |
| Q47811446 | Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: first annual report--2003. |
| Q37975112 | Mechanical circulatory support for elderly heart failure patients |
| Q52899335 | Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. |
| Q51749946 | Outcomes of ventricular assist device support in young patients with small body surface area |
| Q35160117 | Patient selection for left ventricular assist device therapy |
| Q35666569 | Patient selection for left ventricular assist devices |
| Q38006419 | Patient selection for mechanical circulatory support |
| Q44929448 | Perioperative management of ventricular assist devices |
| Q36963623 | Prospective, multicenter study of ventricular assist device infections |
| Q35666579 | Rotary blood pumps for cardiac assistance: a "must"? |
| Q37946224 | Systolic heart failure in the elderly: optimizing medical management |
| Q26824537 | Temporary mechanical circulatory support: a review of the options, indications, and outcomes |
| Q30359726 | The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results |
| Q28216352 | The failing heart |
| Q48792385 | The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types |
| Q51697728 | Under-utilization of mechanical circulatory support in Canada: why and what can be done? |
| Q28247483 | Ventricular assist device-related infections |
| Q36071675 | Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections |
| Q39652568 | Ventricular assist devices in pediatrics |
| Q35724574 | Ventricular assistance to bridge to transplantation |
| Q73880321 | [Circulatory assistance: point of view of anaesthesiologist] |
| Q73880326 | [Circulatory assistance: point of view of surgeon] |
Search more.